Rodgers, Jessica
Wright, Phillip
Ballister, Edward R.
Hughes, Rebecca B.
Storchi, Riccardo
Wynne, Jonathan
Martial, Franck P.
Lucas, Robert J.
Funding for this research was provided by:
Human Frontiers Science Program (RGP0034/2014)
Kubota Vision
Article History
Received: 9 June 2023
Revised: 1 November 2023
Accepted: 2 November 2023
First Online: 1 December 2023
Declarations
:
: All experiments were conducted in accordance with the UK Animals (Scientific Procedures) Act (1986) and approved by the University of Manchester ethical review committee.
: RJL is a named inventor on a patent application for the use of rod opsin as a therapeutic in retinal degeneration, and he has provided consultancy services to Kubota Vision on this topic. RJL, ERB, and JR are named inventors on a patent application related to the work described in this manuscript.